HEDIMED aims to identify the disease mechanisms and environmental factors of type 1 diabetes, celiac disease, asthma, and allergies.

Immune-mediated diseases have reached epidemic levels affecting a large part of the European population and causing ballooning healthcare costs. A major part of the epidemic are type 1 diabetes, celiac disease, asthma, and allergies whose rapid increase can only be explained by environmental exposures.

HEDIMED seeks to understand the interactions of disease-specific and shared environmental determinants in disease development through one of the largest collections of data in the field, and with new technologies and modelling methods.
The results will be used to facilitate the development of treatments and prevention measures for these diseases and to create a toolbox with multiple functions for the research community, patients, and policymakers.

In HEDIMED altogether 22 academic and industrial partners join their multidisciplinary and supplementary forces to identify exposomic determinants which are driving the epidemic of immune-mediated diseases.